PMEF
PROK icon

Point72 Middle East FZE’s ProKidney PROK Stock Holding History

Point72 Middle East FZE’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-31,855
Closed -$56.7K – 1016
2023
Q4 		$56.7K Buy
31,855
+14,867
+88% +$31.9K ﹤0.01% 1272
2023
Q3 		$77.8K Buy
+16,988
New +$163K ﹤0.01% 1187

Other funds holding PROK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 Middle East FZE's PROK Position: Q1 2024 in Review

Point72 Middle East FZE sold out of ProKidney (PROK) in Q1 2024, closing a stake of 31,855 shares — an estimated $56.7K sold.

Point72 Middle East FZE first reported a position in PROK in Q3 2023 and held it in 2 quarters. The position peaked at $77.8K in Q3 2023. 55 funds tracked by Wall St. Rank hold PROK as of Q1 2024.

  • Point72 Middle East FZE reported no remaining ProKidney position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 31,855 ProKidney shares in Q1 2024, an estimated $56.7K.
  • Point72 Middle East FZE first reported a position in ProKidney in Q3 2023 and held it in 2 quarters.
  • Point72 Middle East FZE's ProKidney position peaked at $77.8K in Q3 2023.
  • 55 funds tracked by Wall St. Rank held ProKidney as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.